Individualization at the heart of comparative effectiveness research: The time for i-CER has come

Medical Decision Making

Volumn 29, Issue 6, 2009, Pages

  Basu, Anirban ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; RISPERIDONE;

CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH PROMOTION; MEDICAL DECISION MAKING; MEDICAL RESEARCH; SCHIZOPHRENIA; SHORT SURVEY; THERAPY EFFECT; TREATMENT OUTCOME; UNITED STATES;

CLINICAL TRIALS AS TOPIC; COMPARATIVE EFFECTIVENESS RESEARCH; HEALTH CARE REFORM; HUMANS; UNITED STATES;

EID: 72149084135     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X09351586     Document Type: Short Survey

References (15)

1. Neyman J. Sur les applications de la théorie des probabilities aux experiences agaricales: essay des principle 1923. [English translation of excerpts by Dabrowska D, Speed T.] Stat Sci. 1990 ; 5: 463-472.
2. Fisher RA Design of Experiments. Edinburgh: Oliver and Boyd; 1935.
3. Orszag PR Health costs are the real deficit threat. Wall Street Journal. 15 May 2009. Available from: http://online.wsj.com/article/SB124234365947221489. html
4. Roy AD Some thoughts on the distribution of earnings. Oxford Econ Papers. 1951 ; 3: 135-146.
5. Rubin D. Bayesian inference for causal effects: the role of randomization. Ann Stat. 1978 ; 6: 34-58.
6. Stroup TS, McEvoy JP, Swartz MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull. 2003 ; 29 (1). 15-31.
7. Munkin MK, Trivedi PK Bayesian analysis of self-selection model with multiple outcomes using simulation-based estimation: an application to the demand for healthcare. J Econometrics. 2003 ; 114: 197-220.
8. Heckman JJ, Navarro S. Dynamic discrete choice and dynamic treatment effects. J Econometrics. 2007 ; 136 (2). 341-396.
9. Florens JP, Heckman JJ, Meghir C., Vytlacil E. Identification of treatment effects using control functions in models with continuous, endogenous treatment and heterogeneous effects. Econometrica. 2008 ; 76 (5). 1191-1206.
10. Tunis SR, Stryer DB, Clancy CM Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. J Am Med Assoc. 203 ; 290: 1624-1632.
11. Cheng Y., Berry DA Optimal adaptive randomized designs for clinical trials. Biometrika. 2007 ; 94 (3). 673-689.
12. Murphy SA An experimental design for the development of adaptive treatment strategies. Stat Med. 2005 ; 24: 1455-1481.
13. Senn S. Cross-Over Trials in Clinical Research. 2 nd ed. Hoboken, NJ: Wiley ; 2002.
14. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998 ; 18 (2 suppl). S65-80.
15. Basu A., Meltzer D. Value of information on preference heterogeneity and individualized care. Med Decis Making. 2007 ; 27 (2). 112-127.